Sign in

CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
880724208
Phone
857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,490,340
in 8 filings, $4.5M under 10b5-1 plans

Net +$17,533,565. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −7,925 $33.04 $262K 141,989
2026-09-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −2,075 $33.76 $70K 139,914
2026-06-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −1,900 $40.09 $76K 158,014
2026-06-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −3,792 $41.39 $157K 154,222
2026-06-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −3,308 $42.17 $140K 150,914
2026-06-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −1,000 $43.15 $43K 149,914
2026-03-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −7,161 $28.04 $201K 162,753
2026-03-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −2,839 $28.55 $81K 159,914
2026-03-05 Gault Cheryl Chief Operating Officer Sale −2,014 $28.93 $58K 169,914
2026-02-02 Gault Cheryl Chief Operating Officer Grant or award · Stock Option (Right to Buy) +132,000 132,000
2025-11-26 Gault Cheryl Chief Operating Officer Option exercise 10b5-1 +5,000 $1.80 $9K 176,928
2025-11-26 Gault Cheryl Chief Operating Officer Sale 10b5-1 −5,000 $30.10 $150K 171,928
2025-11-26 Gault Cheryl Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 105,407
2025-09-08 Gault Cheryl Chief Operating Officer Option exercise 10b5-1 +5,000 $1.80 $9K 176,928
2025-09-08 Gault Cheryl Chief Operating Officer Sale 10b5-1 −5,000 $38.33 $192K 171,928
2025-09-08 Gault Cheryl Chief Operating Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −5,000 110,407
2025-03-03 Gault Cheryl Chief Operating Officer Grant or award +13,987 171,928
2025-02-03 Gault Cheryl Chief Operating Officer Grant or award · Stock Option (Right to Buy) +129,000 129,000
2024-06-06 Gault Cheryl Chief Operations Officer Grant or award · Stock Option (Right to Buy) +88,442 88,442

Page 1 of 1 · 19 trades